298 related articles for article (PubMed ID: 1318197)
1. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
Peto M; Tolle-Ersü I; Kreysch HG; Klock G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
[TBL] [Abstract][Full Text] [Related]
3. Activity of human papillomavirus type 16 P97 promoter in immortal and tumorigenic human oral keratinocytes.
Kook JK; Kim JH; Min BM
Int J Oncol; 1998 Oct; 13(4):765-71. PubMed ID: 9735407
[TBL] [Abstract][Full Text] [Related]
4. Different HPV16 E6/E7 oncogene expression patterns in epithelia reconstructed from HPV16-immortalized human endocervical cells and genital keratinocytes.
Sun Q; Tang SC; Pater MM; Pater A
Oncogene; 1997 Nov; 15(20):2399-408. PubMed ID: 9395236
[TBL] [Abstract][Full Text] [Related]
5. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
6. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.
Cripe TP; Haugen TH; Turk JP; Tabatabai F; Schmid PG; Dürst M; Gissmann L; Roman A; Turek LP
EMBO J; 1987 Dec; 6(12):3745-53. PubMed ID: 2448139
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
9. A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA.
Glahder JA; Hansen CN; Vinther J; Madsen BS; Norrild B
J Gen Virol; 2003 Dec; 84(Pt 12):3429-3441. PubMed ID: 14645924
[TBL] [Abstract][Full Text] [Related]
10. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.
Stünkel W; Huang Z; Tan SH; O'Connor MJ; Bernard HU
J Virol; 2000 Mar; 74(6):2489-501. PubMed ID: 10684263
[TBL] [Abstract][Full Text] [Related]
11. Cellular control of human papillomavirus oncogene transcription.
Hoppe-Seyler F; Butz K
Mol Carcinog; 1994 Jul; 10(3):134-41. PubMed ID: 8043195
[TBL] [Abstract][Full Text] [Related]
12. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
13. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
14. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
[TBL] [Abstract][Full Text] [Related]
16. The synergistic transactivation of the hepatitis B viral (HBV) pregenomic promoter by the E6 protein of human papillomavirus type 16 (HPV-16 E6) with HBV X protein was mediated through the AP1 site of E element in the enhancer I (EnI) in human liver cell.
Lee DH; Choi BH; Rho HM
Biochem Biophys Res Commun; 1999 Nov; 265(1):62-6. PubMed ID: 10548491
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region.
Yasumoto S; Taniguchi A; Sohma K
J Virol; 1991 Apr; 65(4):2000-9. PubMed ID: 1848315
[TBL] [Abstract][Full Text] [Related]
18. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells.
Mack DH; Laimins LA
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9102-6. PubMed ID: 1656460
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7.
Nasseri M; Gage JR; Lorincz A; Wettstein FO
Virology; 1991 Sep; 184(1):131-40. PubMed ID: 1651587
[TBL] [Abstract][Full Text] [Related]
20. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
